ArticlePloS one2026
Italy's progress towards the objectives of the national action plan to combat antimicrobial resistance.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntimicrobial resistance (AMR) represents a major public health threat. Italian AMR rates are among the highest in Europe. The Italian National action plan to combat AMR was launched in 2017 and updated in 2022. To monitor its implementation, the self-assessment tool SPiNCAR (Supporto al Piano nazionale per il contrasto all'antimicrobico resistenza) was developed.
methodsWe conducted the first national data collection through SPiNCAR in 2023, assessing the level of implementation across Italian regions and autonomous provinces for the year 2022. Regional SPiNCAR scores were correlated with relevant indicators: healthcare-associated infection (HAI) and antimicrobial use prevalence, as well as antibiotic consumption.
resultsThirteen regions and autonomous provinces participated. High implementation levels were observed in the SPiNCAR areas of governance, surveillance, HAI prevention and control, and antimicrobial stewardship, while education, stakeholder engagement, and performance assessment showed the lowest scores. Moderate inverse correlations emerged between governance scores and HAI prevalence, and between surveillance/appropriate use scores and antimicrobial use prevalence. A strong inverse correlation was found between performance assessment scores and antimicrobial use prevalence.
conclusionsThis study provides the first national baseline assessment of the level of implementation of the Italian National action plan to combat AMR. Results suggest SPiNCAR could be a useful tool to monitor AMR policies in decentralized health systems. Findings highlight both achievements and gaps; repeated assessments are necessary to guide targeted interventions and reduce regional inequalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.